Remove 2021 Remove Drug Development Remove Health Data Remove Telehealth
article thumbnail

6 challenges healthtech can help us tackle – Pt.2

Digital Health Global

Wearable monitoring devices, genomics, and AI play vital roles in this transformation, enabling personalized interventions and collective health data sharing for research. There are three main advantages to the use of AI in drug development: width of research, speed of execution, low costs. 2021 [6] Regina M.

article thumbnail

Teladoc Livongo merger: what went wrong with the 'one-stop shop for virtual care' strategy?

Lloyd Price

2021: The integration of the two companies is underway. 2022: Teladoc faces challenges in the market for digital health. History of Teladoc Teladoc Health is a multinational telemedicine and virtual healthcare company headquartered in the United States. October 30, 2020: The merger is completed.